Micro Emerging Active

Lexicon Pharmaceuticals' Sotagliflozin Post-hoc Analyses

New narrative with limited coverage — still forming.

Score
0.2
Velocity
▲ 0.0
Articles
2
Sources
1

Top Movers

TickerSectorChange
LXRX
Healthcare+35.1%

Sentiment Timeline

Sector Performance

Event Timeline

Apr 24, 2026
Lexicon Pharmaceuticals (LXRX) to Present Phase 2b Pilavapadin Data Neutral
Mar 22, 2026
H.C. Wainwright Remains a Buy on Lexicon Pharmaceuticals (LXRX) Neutral

Related Articles

H.C. Wainwright Remains a Buy on Lexicon Pharmaceuticals (LXRX)

Yahoo Finance · Mar 22, 2026
Mixed

Timeline

First SeenMar 22, 2026
Last UpdatedMar 22, 2026